Treatment Pathways Leading to Biologic Therapies for Ulcerative Colitis and Crohn's Disease in the United States

Biologic therapies have been available for inflammatory bowel disease for >20 years, but patient outcomes have not changed appreciably over this time period. To better understand medication utilization for this disease, we evaluated a novel technique for visualizing treatment pathways, including...

Descripción completa

Detalles Bibliográficos
Autores principales: Siegel, Corey A., Yang, Fei, Eslava, Sergio, Cai, Zhaohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145024/
https://www.ncbi.nlm.nih.gov/pubmed/32463619
http://dx.doi.org/10.14309/ctg.0000000000000128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145024/
https://www.ncbi.nlm.nih.gov/pubmed/32463619
http://dx.doi.org/10.14309/ctg.0000000000000128

Ejemplares similares